The expanding demand in peptides has given rise to a large grey sector, presenting serious risks to users. These items are often manufactured without rigorous official oversight, meaning the quality and efficacy can be highly variable. In addition, these sources may omit correct details regarding components, likely side effects, and appropriate adm